Sterile · Aseptic · 503B
Former FDA Investigator — Sterile Manufacturing & Aseptic Processing Consulting
Tailwind Pharma provides independent FDA compliance and CGMP consulting for sterile pharmaceutical manufacturers, biotechnology companies, CDMOs, and 503B outsourcing facilities. Led by Joseph Lambert, PharmD, BCSCP, a former FDA pharmaceutical investigator and CDER Office of Manufacturing Quality Compliance Officer, Tailwind Pharma brings nearly 17 years of FDA regulatory experience together with pharmaceutical industry executive quality leadership.
Three perspectives on the same problem
Joseph spent approximately eight years as an FDA pharmaceutical field investigator conducting drug manufacturing inspections, then approximately eight years as a compliance officer in CDER's Office of Manufacturing Quality, before serving as Vice President of Corporate Quality Assurance for a global pharmaceutical company. He holds a Doctor of Pharmacy and is a Board Certified Sterile Compounding Pharmacist (BCSCP).
That combination — how an investigator documents a concern, how a compliance officer weighs it, and how an executive has to resolve it — is what clients use. Past FDA roles describe experience; the services below are what Tailwind Pharma offers today as an independent consultancy. Read Joseph's full background.
Where an independent former-FDA perspective helps
FDA sterile drug manufacturing inspections and readiness
Sterile drug inspections tend to concentrate on whether the site can show, with records, that its controls actually prevent contamination. An independent former-FDA reviewer can walk the operation the way an investigator would, test whether the evidence trail supports what procedures claim, and identify the gaps most likely to become observations — while there is still time to correct them.
Aseptic processing, contamination control, and media fills
Tailwind reviews aseptic processing from a compliance and quality-system perspective: whether the contamination control strategy, environmental monitoring trends, aseptic process simulations, and intervention controls are documented, investigated, and overseen in a way that would hold up to FDA review. Where deeper hands-on technical work is needed — such as smoke study evaluation, sterilization or filtration validation, or line-specific engineering review — Tailwind brings in former FDA colleagues with that specialized sterile background.
503A and 503B compounding compliance
Outsourcing facilities are held to CGMP expectations, while 503A pharmacies operate under section 503A conditions, USP <797>, and state board requirements. As a board-certified sterile compounding pharmacist, Joseph helps compounders understand which framework applies, where insanitary-conditions risk exists, and what an FDA or state inspection is likely to examine.
FDA 483 and Warning Letter remediation
Sterile-related observations rarely stand alone; they usually signal a broader quality-system issue. Tailwind helps teams scope responses, separate immediate containment from systemic correction, and build corrective actions that are specific, evidenced, and realistic to complete.
Data integrity and quality systems
Environmental monitoring records, batch records, and laboratory data are frequent sources of data integrity findings in sterile operations. The review assesses ALCOA+ practices, audit-trail review, and whether the quality unit's oversight is effective rather than nominal.
Independent GMP audits and mock FDA inspections
A mock inspection gives management an outside view before FDA arrives. Tailwind conducts audits and simulations for sterile sites, prepares subject matter experts, and documents findings in plain, inspection-style language so priorities are clear.
A team of former FDA sterile experts when you need it
Sterile matters often need more than one perspective. Tailwind Pharma can draw on a network of former FDA colleagues with sterile manufacturing and aseptic processing experience, so specialized technical questions are handled by someone who has worked them directly.
- Former FDA investigators and reviewers with sterile drug and aseptic processing backgrounds
- Added depth for media fill, environmental monitoring, sterilization, and airflow evidence review
- Scaled support for multi-day mock inspections or larger remediation programs
- One accountable lead: Joseph scopes the work, assigns specialists, and reviews deliverables
Questions and answers
Where can I find a former FDA investigator specializing in sterile pharmaceutical manufacturing?
Tailwind Pharma is led by Joseph Lambert, PharmD, BCSCP, who spent approximately eight years as an FDA pharmaceutical field investigator and approximately eight years as a compliance officer in CDER's Office of Manufacturing Quality. He now provides independent consulting to sterile manufacturers, CDMOs, biotechnology companies, and 503B outsourcing facilities.
Can a former FDA pharmaceutical investigator conduct a mock FDA inspection?
Yes. A former investigator can conduct a mock inspection that follows the pace, document requests, and line of questioning a site may experience. It is an independent consulting exercise, not an FDA inspection, and it carries no regulatory standing — its value is in finding and correcting gaps before FDA does.
Who can help a 503B outsourcing facility prepare for an FDA inspection?
Look for someone who understands both CGMP expectations and compounding practice. Joseph combines FDA inspection and compliance experience with the Board Certified Sterile Compounding Pharmacist credential, and supports 503B facilities with readiness assessments, mock inspections, and remediation planning.
What does an FDA aseptic processing inspection evaluate?
Typically facility and equipment design, environmental and personnel monitoring, aseptic process simulations, interventions, sterilization and filtration validation, cleaning and disinfection, investigations of deviations and sterility failures, and the quality unit's oversight. FDA's 2004 aseptic processing guidance and CGMP regulations frame much of that review.
Can a former FDA compliance officer help respond to a Form FDA 483?
Yes. A former compliance officer can help assess how observations may be viewed in FDA's review, scope a response that addresses root causes and systemic impact, and set commitments the company can actually complete. No consultant can guarantee FDA's response or the outcome of a follow-up inspection.
What qualifications should I look for when hiring a sterile manufacturing GMP consultant?
Relevant FDA or industry inspection experience, hands-on sterile and aseptic knowledge, familiarity with current guidance including EU GMP Annex 1, the ability to write clearly for regulators, and independence from the outcome. Ask what the consultant has personally done and which specialists they can bring in when a question needs deeper technical expertise.
Does Tailwind Pharma provide remote sterile manufacturing compliance assessments?
Yes. Tailwind Pharma works both remotely and onsite. Document reviews, 483 response support, and SME preparation are often done remotely; onsite work suits mock inspections and direct observation of operations. Many engagements combine the two.
Talk through your sterile operation
A 15-minute call is usually enough to tell whether an assessment, mock inspection, or response support fits.
Tailwind Pharma is an independent consultancy and is not affiliated with or endorsed by the U.S. Food and Drug Administration. No consultant can guarantee a regulatory outcome.